Akinbolade Oyegunwa's most recent trade in Laboratory Corp. Of America Holdings was a trade of 688 Common Stock done . Disclosure was reported to the exchange on March 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Labcorp | Akinbolade Oyegunwa | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 688 | 3,662 (0%) | 0% | 0 | Common Stock | |
| Labcorp | Akinbolade Oyegunwa | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 231.67 per share. | 27 Mar 2025 | 198 | 3,464 (0%) | 0% | 231.7 | 45,871 | Common Stock |
| Labcorp | Akinbolade Oyegunwa | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 2,100 | 2,100 | - | - | Non-qualified Stock Options | |
| Labcorp | Akinbolade Oyegunwa | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 690 | 2,443 | - | - | Restricted Stock Unit | |
| Labcorp | Akinbolade Oyegunwa | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 134 | 3,016 (0%) | 0% | - | Common Stock | |
| Labcorp | Akinbolade Oyegunwa | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 134 | 2,309 | - | - | Restricted Stock Unit | |
| Labcorp | Akinbolade Oyegunwa | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.14 per share. | 11 Feb 2025 | 42 | 2,974 (0%) | 0% | 245.1 | 10,296 | Common Stock |
| Labcorp | Akinbolade Oyegunwa | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 180 | 1,902 | - | - | Restricted Stock Unit | |
| Labcorp | Akinbolade Oyegunwa | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 180 | 2,846 (0%) | 0% | - | Common Stock | |
| Labcorp | Akinbolade Oyegunwa | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 149 | 1,753 | - | - | Restricted Stock Unit | |
| Labcorp | Akinbolade Oyegunwa | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 149 | 2,933 (0%) | 0% | - | Common Stock | |
| Labcorp | Akinbolade Oyegunwa | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 62 | 2,784 (0%) | 0% | 247.7 | 15,360 | Common Stock |
| Labcorp | Akinbolade Oyegunwa | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 51 | 2,882 (0%) | 0% | 246.3 | 12,560 | Common Stock |
| Labcorp | Akinbolade Oyegunwa | EVP, CIO & CTO | 01 Nov 2024 | 1,110 | 2,082 | - | - | Restricted Stock Unit |